OREX fda advisory panel votes 11-8 to back new trial after approval of contrave...please note that this is just one of the votes/issues in front of panel
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.